Molecule Details
| InChIKey | QJJXYPPXXYFBGM-LFZNUXCKSA-N |
|---|---|
| Compound Name | Tacrolimus |
| Canonical SMILES | C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 11 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.43 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00864 |
|---|---|
| Drug Name | Tacrolimus |
| CAS Number | 104987-11-3 |
| Groups | approved investigational |
| ATC Codes | D11AH01 L04AD02 |
| Description | Tacrolimus (also FK-506 or Fujimycin) is an immunosuppressive drug whose main use is after organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refracto... |
Categories: Agents Causing Muscle Toxicity Agents causing hyperkalemia Agents for Dermatitis, Excluding Corticosteroids Antineoplastic and Immunomodulating Agents Calcineurin Inhibitor Immunosuppressant Calcineurin Inhibitors Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dermatologicals Drugs causing inadvertant photosensitivity Enzyme Inhibitors Hyperglycemia-Associated Agents Immunologic Factors Immunosuppressive Agents Lactones Misc. Skin and Mucous Membrane Agents Myelosuppressive Agents Narrow Therapeutic Index Drugs Nephrotoxic agents OATP1B1/SLCO1B1 Inhibitors P-glycoprotein inducers P-glycoprotein inhibitors P-glycoprotein substrates P-glycoprotein substrates with a Narrow Therapeutic Index Photosensitizing Agents Polyketides Potential QTc-Prolonging Agents QTc Prolonging Agents
Cross-references: BindingDB: 50079777 ChEBI: 61049 CHEMBL269732 ChemSpider: 393220 Drugs Product Database (DPD): 167 C01375 D00107 PDB: FK5 PharmGKB: PA451578 PubChem:445643 PubChem:46506004 RxCUI: 235991 Therapeutic Targets Database: DAP000162 Wikipedia: Tacrolimus ZINC: ZINC000169289411
Target Activities (11)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P68106 | FKBP1B | Homo sapiens | Human | PF00254 | 9.4 | Kd | ChEMBL;BindingDB |
| P62942 | FKBP1A | Homo sapiens | Human | PF00254 | 8.8 | IC50 | ChEMBL;BindingDB |
| P42345 | MTOR | Homo sapiens | Human | PF02259 PF02260 PF08771 PF23593 PF11865 PF00454 | 8.8 | IC50 | ChEMBL;BindingDB |
| Q15393 | SF3B3 | Homo sapiens | Human | PF10433 PF23726 PF03178 | 7.9 | IC50 | ChEMBL |
| Q08209 | PPP3CA | Homo sapiens | Human | PF00149 | 7.8 | IC50 | ChEMBL;BindingDB |
| Q02790 | FKBP4 | Homo sapiens | Human | PF00254 PF00515 PF07719 | 7.2 | Kd | ChEMBL |
| Q13451 | FKBP5 | Homo sapiens | Human | PF00254 PF00515 PF13181 | 7.1 | Ki | ChEMBL;BindingDB |
| P08684 | CYP3A4 | Homo sapiens | Human | PF00067 | 6.2 | IC50 | ChEMBL;BindingDB |
| P20815 | CYP3A5 | Homo sapiens | Human | PF00067 | 6.2 | IC50 | ChEMBL;BindingDB |
| P24462 | CYP3A7 | Homo sapiens | Human | PF00067 | 6.2 | IC50 | ChEMBL |
| Q9HB55 | CYP3A43 | Homo sapiens | Human | PF00067 | 6.2 | IC50 | ChEMBL |
DrugBank Target Actions (11)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P02763 | P02763 | Alpha-1-acid glycoprotein 1 | substrate | carriers |
| P02768 | ALB | Albumin | substrate | carriers |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P20815 | CYP3A5 | Cytochrome P450 3A5 | substrate | enzymes |
| P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | inhibitor | targets |
| Q08209 | PPP3CA | Protein phosphatase 3 catalytic subunit alpha | inhibitor | targets |
| P08183 | ABCB1 | ATP-dependent translocase ABCB1 | inducer | transporters |
| P08183 | ABCB1 | ATP-dependent translocase ABCB1 | inhibitor | transporters |
| Q9Y6L6 | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | inhibitor | transporters |
| P08183 | ABCB1 | ATP-dependent translocase ABCB1 | substrate | transporters |
| Q8WWZ7 | Q8WWZ7 | Cholesterol transporter ABCA5 | substrate | transporters |